Rubicon Organics Stock Price, News & Analysis

Rubicon Organics (OTCQX: ROMJF) published its fifth annual ESG Report covering January 1 to December 31, 2024. The report highlights five-year progress since 2020 across business, governance, environment, and social metrics.

Key figures: net revenue rose 410% from $9.4M in 2020 to $49M in 2024; energy use increased 17% and water use increased 58% over the same period. Governance disclosures include board oversight and CEO pay ratio. Social metrics show 80% employee pride and 86% engagement survey participation (94% for temporary foreign workers).

Rubicon Organics (OTCQX: ROMJF) announced that its Cascadia facility in Hope, British Columbia, received a Health Canada licence to cultivate, process, and store cannabis.

The purpose-built, 47,500 sq ft indoor site adds 4,500 kg of annual production capacity, a 40% incremental increase that brings Rubicon's total premium annual capacity to 15,500 kg. Operations are underway and the company expects first revenue in H1 2026. Management said the facility uses advanced cultivation technologies and will support domestic demand and international market opportunities. Rubicon also renamed its Delta facility to Pacifica.

Rubicon Organics (OTCQX: ROMJF), Canada's leading premium licensed producer of organic certified cannabis products, has announced its participation in two upcoming investor events. The company will present at Small Cap Discoveries in Vancouver (September 29-30) and the Planet MicroCap Showcase in Toronto (October 21-23).

Additionally, Rubicon has engaged Atrium Research Corporation for research services at $3,500 monthly for 12 months starting October 1st, 2025, pending TSXV approval.

Rubicon Organics (OTCQX: ROMJF), Canada's leading premium organic cannabis producer, reported strong Q2 2025 financial results with net revenue of $15.0 million, up 24% year-over-year. The company achieved Adjusted EBITDA of $1.4 million and positive operating cash flow of $0.8 million.

Key developments include the acquisition of the Hope Facility, increasing production capacity by 40% to 15,500 kg annually, and completion of a $4.5 million private placement. The company expanded its product portfolio with the launch of 1964 Premium All-in-One Resin Vapes and maintained strong market share positions: 5.2% in premium flower/pre-rolls, 15.1% in resin vapes, and 26.2% in premium edibles.

For 2025, Rubicon expects growth in both revenue and Adjusted EBITDA, despite anticipated one-time costs of $1-2 million related to the Hope Facility start-up. The company is also exploring international market opportunities while maintaining focus on Canadian market leadership.

Rubicon Organics (OTCQX:ROMJF), a licensed producer specializing in organic certified and premium cannabis products, has scheduled its Q2 2025 financial results release for August 18, 2025, before market open.

The company will host a conference call to discuss the results on the same day at 7:00 AM PT / 10:00 AM ET. Investors can access the call through local dial-in, toll-free North American number, or via webcast through the company's earnings call registration.

Rubicon Organics (OTCQX: ROMJF), a premium cannabis producer, held its Annual General and Special Meeting with 46.3% shareholder representation. Shareholders approved all proposed matters, including setting the board size at eight directors and electing all nominated directors with approval rates ranging from 85.7% to 95.8%.

The company announced a significant leadership change as Len Boggio steps down as Board Chair, transitioning to Chair of the Nomination and Governance Committee. Doris Bitz, an independent director since 2023 with over 30 years of CPG and manufacturing experience, has been appointed as the new Board Chair.

Shareholders also approved amendments to the company's Omnibus Equity Incentive Plan with 74.7% support. The plan allows for a maximum of 8,960,180 Common Shares for equity awards. Additionally, the company granted 1,024,576 DSUs to independent directors, vesting in twelve months.

Rubicon Organics (OTCQX: ROMJF), a licensed producer of organic certified and premium cannabis, has announced its upcoming Annual General and Special Meeting scheduled for July 31, 2025, at 10:00 AM PT. The meeting will be held at the Terminal City Club in Vancouver, with a live webcast option available.

The meeting agenda includes receiving 2024 financial statements, setting the board size at eight directors, electing directors, appointing PricewaterhouseCoopers LLP as auditors, and considering an amendment to the Omnibus Equity Incentive Plan to reserve 8,960,179 Common Shares for issuance. The record date for the meeting was set for June 25, 2025.

Rubicon Organics (OTCQX: ROMJF) has announced the launch of its new 1964 Supply Co.™ All-in-One (AIO) Full Spectrum Extract (FSE) Resin Vapes in the Canadian market. The product features the Comatose strain in a 0.5 gram format and will initially launch in British Columbia before expanding to other major Canadian provinces, excluding Quebec.

The launch follows the successful introduction of 510 FSE resin vape cartridges in May 2024. The company plans to launch two additional AIO offerings by the end of 2025. The product aims to attract legacy market consumers by offering high-quality FSE resin vapes at competitive price points, distinguishing itself in a market dominated by distillate-based products.

Rubicon Organics (ROMJF) has acquired a 47,500 sq. ft. indoor cultivation facility in Hope, British Columbia, marking a significant expansion of its premium cannabis production capacity. The purpose-built facility is expected to increase the company's annual production capacity by 4,500 kgs, representing a 40% increase from their current Delta Facility. This brings Rubicon's total annual production potential to 15,500 kg of premium cannabis. The company plans to invest approximately $3 million in operating startup costs during 2025, with cultivation rooms expected to be planted by year-end and full production capacity targeted for the end of 2026. Revenue contribution from the Hope Facility is anticipated to begin in the first half of 2026.